ClinVar Miner

Submissions for variant NM_003000.3(SDHB):c.183T>G (p.Tyr61Ter)

dbSNP: rs760169139
Minimum review status: Collection method:
Minimum conflict level:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital RCV006554546 SCV007449333 pathogenic Pheochromocytoma/paraganglioma syndrome 4 2024-07-30 criteria provided, single submitter clinical testing This variant is predicted to result in loss of function through nonsense-mediated decay of the encoded transcript or premature truncation of the encoded protein in a gene in which loss of function is a known mechanism of disease (ACMG/AMP: PVS1; PMIDs:19454582, 19802898). This variant has been reported at an elevated frequency in affected individuals/in multiple affected individuals in the literature (ACMG/AMP: PS4_Supporting; PMIDs:20418362, 22723792). This variant is absent from or present at an exceedingly low frequency in gnomAD, a large-scale control population database (ACMG/AMP: PM2).
Quest Diagnostics Nichols Institute San Juan Capistrano RCV003320666 SCV007109974 pathogenic not provided 2025-06-17 criteria provided, single submitter clinical testing The SDHB c.183T>G (p.Tyr61*) variant causes the premature termination of SDHB protein synthesis. This variant has been reported in the published literature in individuals affected with pheochromocytoma/paraganglioma (PMID: 28374168 (2017), 20418362 (2010)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic.
GeneDx RCV003320666 SCV004025581 pathogenic not provided 2025-05-28 criteria provided, single submitter clinical testing Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 19958924, 31492822, 22723792, 28374168, 34439168, 20418362)
Ambry Genetics RCV002413384 SCV002717032 pathogenic Hereditary cancer-predisposing syndrome 2024-12-18 criteria provided, single submitter clinical testing The p.Y61* pathogenic mutation (also known as c.183T>G), located in coding exon 2 of the SDHB gene, results from a T to G substitution at nucleotide position 183. This changes the amino acid from a tyrosine to a stop codon within coding exon 2. This alteration has been detected in multiple individuals diagnosed with a paraganglioma or pheochromocytoma (Lodish MB et al. Endocr Relat Cancer. 2010 Sep;17:581-8; Jochmanova I et al. J Cancer Res Clin Oncol. 2017 Aug;143:1421-1435; Ambry internal data). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
MGZ Medical Genetics Center RCV002289690 SCV002579716 pathogenic Pheochromocytoma 2021-12-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001389812 SCV001591295 pathogenic Gastrointestinal stromal tumor; Pheochromocytoma/paraganglioma syndrome 4; Pheochromocytoma 2025-05-05 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr61*) in the SDHB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHB are known to be pathogenic (PMID: 19454582, 19802898). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with paraganglioma (PMID: 20418362). ClinVar contains an entry for this variant (Variation ID: 438412). For these reasons, this variant has been classified as Pathogenic.
Section on Medical Neuroendocrinolgy, National Institutes of Health RCV000505331 SCV000599487 pathogenic Hereditary pheochromocytoma and paraganglioma no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The submitted information has not been verified. If you have questions about the information contained on this website, please see a health care professional.